Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effects.
Fusco V, Di Maio M, Valsecchi AA, Santini D, Tucci M, De Giorgi U, Bossi P, Ibrahim T, Cavanna L, Lanzetta G, Rossi M, Rossetti G, Airoldi M, Comandone A, Cinieri S. Fusco V, et al. Among authors: lanzetta g. Support Care Cancer. 2024 Mar 1;32(3):202. doi: 10.1007/s00520-024-08392-8. Support Care Cancer. 2024. PMID: 38427111 Free PMC article.
Long-term treatment outcomes of temozolomide-based chemoradiation in patients with adult-type diffuse IDH-mutant grade 2 astrocytoma.
Minniti G, Paolini S, Antonelli M, Gianno F, Tini P, Lanzetta G, Arcella A, De Pietro R, Giraffa M, Capone L, Romano A, Bozzao A, Esposito V. Minniti G, et al. Among authors: lanzetta g. J Neurooncol. 2023 Sep;164(2):331-339. doi: 10.1007/s11060-023-04418-z. Epub 2023 Sep 4. J Neurooncol. 2023. PMID: 37665475 Free PMC article.
A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors.
Mezi S, Pomati G, Fiscon G, Amirhassankhani S, Zizzari IG, Napoletano C, Rughetti A, Rossi E, Schinzari G, Tortora G, Lanzetta G, D'Amati G, Nuti M, Santini D, Botticelli A. Mezi S, et al. Among authors: lanzetta g. Front Immunol. 2023 Jul 7;14:1199089. doi: 10.3389/fimmu.2023.1199089. eCollection 2023. Front Immunol. 2023. PMID: 37483633 Free PMC article.
Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study.
Procopio G, Chiuri VE, Giordano M, Alitto AR, Maisano R, Bordonaro R, Cinieri S, Rossetti S, De Placido S, Airoldi M, Galli L, Gasparro D, Ludovico GM, Guglielmini PF, Carella C, Nova P, Aglietta M, Schips L, Beccaglia P, Sciarra A, Livi L, Santini D; ABItude Study Group. Procopio G, et al. ESMO Open. 2022 Apr;7(2):100431. doi: 10.1016/j.esmoop.2022.100431. Epub 2022 Apr 8. ESMO Open. 2022. PMID: 35405438 Free PMC article.
Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases.
Minniti G, Lanzetta G, Capone L, Giraffa M, Russo I, Cicone F, Bozzao A, Alongi F, Nicosia L, Fineschi G, Marchetti L, Tufo T, Bianciardi F, Esposito V, Gentile P, Paolini S. Minniti G, et al. Among authors: lanzetta g. J Immunother Cancer. 2021 Dec;9(12):e003730. doi: 10.1136/jitc-2021-003730. J Immunother Cancer. 2021. PMID: 34949695 Free PMC article.
The role of opioids in cancer response to immunotherapy.
Botticelli A, Cirillo A, Pomati G, Cerbelli B, Scagnoli S, Roberto M, Gelibter A, Mammone G, Calandrella ML, Cerbelli E, Di Pietro FR, De Galitiis F, Lanzetta G, Cortesi E, Mezi S, Marchetti P. Botticelli A, et al. Among authors: lanzetta g. J Transl Med. 2021 Mar 23;19(1):119. doi: 10.1186/s12967-021-02784-8. J Transl Med. 2021. PMID: 33757546 Free PMC article.
Second medical opinion in oncological setting.
Maruzzo M, La Verde N, Russo A, Marchetti P, Scagnoli S, Gonzato O, Di Maio M, Zagonel V, Galvano A, Lanzetta G, Perrone F, Beretta G, Bordonaro R, Comandone A, Cinieri S, Nicolis F, Gori S. Maruzzo M, et al. Among authors: lanzetta g. Crit Rev Oncol Hematol. 2021 Apr;160:103282. doi: 10.1016/j.critrevonc.2021.103282. Epub 2021 Mar 3. Crit Rev Oncol Hematol. 2021. PMID: 33675905 Free article. Review.
Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results from AINO study (Italian Association for Neuro-Oncology).
Villani V, Anghileri E, Prosperini L, Lombardi G, Rudà R, Gaviani P, Rizzato S, Lanzetta G, Fabi A, Scaringi C, Pronello E, Simonetti G, Targato G, Pace A. Villani V, et al. Among authors: lanzetta g. J Neurol. 2021 Aug;268(8):2866-2875. doi: 10.1007/s00415-021-10438-4. Epub 2021 Feb 20. J Neurol. 2021. PMID: 33609154
82 results